Showing results (131-140 of 630) with videos related to
Sort By:
Pageof 63
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1975
Intravascular coagulation in pregnancy--treatment with heparinI M Nilsson, U Hedner, B Astedt, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 1, 1995
Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced haemophilia AE Erhardtsen, M Ezban, M T Madsen, et al.Journal of Thrombosis and Haemostasis : JTH|December 1, 2010
Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following intravenous administration in hemophilia patientsH Agersø, D F Brophy, H Pelzer, et al.Thrombosis Research|September 15, 1989
Subcutaneous treatment of deep venous thrombosis with low molecular weight heparin. A dose finding study with LMWH-NovoA Siegbahn, S Y-Hassan, J Boberg, et al.Thrombosis and Haemostasis|April 1, 1996
Experimental haemorrhagic effect of two-domain non-glycosylated tissue factor pathway inhibitor compared to low molecular weight heparinJ Holst, B Lindblad, S E Matthíasson, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|May 13, 2009
Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors: analysis of HemoRec registry data from the Czech RepublicP Salaj, P Brabec, M Penka, et al.Proceedings of the National Academy of Sciences of the United States of America|June 1, 1985
Polymorphism of normal factor IX detected by mouse monoclonal antibodiesA Wallmark, R Ljung, I M Nilsson, et al.European Journal of Clinical Pharmacology|January 1, 1984
Actions and interactions of acetylsalicylic acid, salicylic acid and diflunisal on platelet aggregationE Nitelius, B Brantmark, B Fredholm, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Antithrombotic efficacy of inactivated active site recombinant factor VIIa is shear dependent in human bloodU Orvim, R M Barstad, L Orning, et al.Thrombosis and Haemostasis|September 1, 1993
Pharmacokinetics of full length and two-domain tissue factor pathway inhibitor in combination with heparin in rabbitsC Bregengaard, O Nordfang, P Ostergaard, et al.Pageof 63